Gene & Cell therapies have arrived, and bring with them important challenges.
Our Task Force, including some of our members active in gene and cell therapies, have worked on a position paper addressing some important questions raised by these novel techniques.
The paper sets out our take on
- HTA and evidential options
- Funding solutions
- Patient access and cross-border healthcare
This paper is the first step of a greater work and reflection from EUCOPE on how our health systems in Europe can embrace these technologies, seen by many as real game-changers for patients. We will further disseminate our paper and discuss with our partners and stakeholders at the EU and national level to bring those revolutionary solutions to patients.
December 16, 2018